Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients. Issue 8 (3rd August 2019)

Record Type:: Journal Article
Title:: Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients. Issue 8 (3rd August 2019)
Main Title:: Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients
Authors:: Nicolè, Stefano
Lanzafame, Massimiliano
Lattuada, Emanuela
Luise, Dora
Vecchi, Marta
Tacconelli, Evelina
Vento, Sandro
Abstract:
Is Part Of:: Infectious diseases. Volume 51:Issue 8(2019)
Journal:: Infectious diseases
Issue:: Volume 51:Issue 8(2019)
Issue Display:: Volume 51, Issue 8 (2019)
Year:: 2019
Volume:: 51
Issue:: 8
Issue Sort Value:: 2019-0051-0008-0000
Page Start:: 615
Page End:: 617
Publication Date:: 2019-08-03
Subjects:: Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
616.9
Journal URLs:: http://www.tandfonline.com/loi/infd19#.VksX11Inzcs ↗
http://informahealthcare.com/loi/inf ↗
http://www.tandfonline.com/ ↗
DOI:: 10.1080/23744235.2019.1609078 ↗
Languages:: English
ISSNs:: 2374-4235
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16419.xml